How do clinical trials for cancer work
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
How Cancer Clinical Trials Work
Clinical trials are research studies that test new cancer treatments to see if they're safe and effective. Let me walk you through how they're structured and what to expect if you're considering participating.
The Basic Structure
Phases of Development:
Cancer treatments go through several phases before becoming standard care:
-
Phase 1 trials focus on safety and dosage. Researchers give the treatment to small groups (20-100 patients) to find the right dose and identify side effects. The goal isn't to cure cancer yet—it's to make sure the treatment is safe enough to study further.
-
Phase 2 trials test whether the treatment actually works against cancer. These involve 100-300 patients and measure how many people respond to treatment and how long that response lasts.
-
Phase 3 trials compare the new treatment to the current standard treatment. These are larger studies (1,000+ patients) that help determine if the new approach is better, worse, or equivalent to what doctors already use.
-
Phase 4 trials happen after FDA approval and monitor long-term safety and effectiveness in real-world use.
How Trials Are Organized
Randomization: In many Phase 2 and 3 trials, patients are randomly assigned to receive either the new treatment or the standard treatment. This removes bias and helps researchers fairly compare the options. You don't get to choose which group you're in—it's like a coin flip.
Blinding: Some trials are "blinded," meaning patients (and sometimes doctors) don't know which treatment is being given. This prevents expectations from influencing results.
Eligibility Requirements: Trials have strict inclusion and exclusion criteria. Your cancer type, stage, previous treatments, overall health, and other factors determine whether you qualify. These rules exist to ensure the trial tests what it's designed to test.
What Participation Involves
- Regular visits to the research center for treatment, blood work, and imaging scans
- Detailed monitoring of side effects and how your cancer responds
- Informed consent — you receive written information about risks and benefits before deciding
- The right to withdraw at any time without affecting your regular care
- No cost for the trial treatment itself (though you may pay for standard care costs)
Potential Benefits and Risks
Possible Benefits:
- Access to cutting-edge treatments before they're widely available
- Close monitoring by research teams
- Contributing to medical knowledge that helps future patients
- Potential therapeutic benefit if the new treatment works
Potential Risks:
- The new treatment might not work as well as hoped
- Unknown or serious side effects could occur
- The trial might require more time and visits than standard treatment
- You might be randomized to the control group (standard treatment)
Finding Trials
According to the National Cancer Institute (NCI), you can search for trials at:
- ClinicalTrials.gov — the official U.S. registry of clinical trials
- Your cancer center's research department
- Your oncologist (they often know about relevant trials)
- Cancer.gov — NCI's patient information portal
Questions to Ask Your Doctor
If you're considering a trial:
- Are there any clinical trials appropriate for my specific cancer type and stage?
- What is the new treatment being tested, and how does it differ from standard treatment?
- What phase is this trial in, and what are the goals?
- What are the known risks and potential benefits for someone in my situation?
- If I'm randomized to the control group, will I receive standard treatment?
- How often would I need to visit the research center, and what would that involve?
- What happens to my care if I experience serious side effects or want to withdraw?
Important Context
According to ASCO (American Society of Clinical Oncology), clinical trials are essential for advancing cancer care. Every treatment that's now standard—from chemotherapy to immunotherapy to targeted drugs—was once tested in a clinical trial. Your participation, if you choose it, directly contributes to helping future patients.
However, participating in a trial is entirely voluntary. Standard treatment options are always available whether or not you participate in research.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with clinical trials for cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2